E-cigarettes and Cardiovascular Function

NACompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

April 21, 2020

Study Completion Date

December 23, 2020

Conditions
Smoking CessationCardiovascular DiseasesMicrocirculationMacrocirculation
Interventions
OTHER

Electronic Cigarette and behavioural change support.

The nicotine strength of Group A (nicotine-inclusive e-cigarettes) cartridges will be 18 mg/ml of nicotine strength. All participants will receive up to 6 behavioural change support sessions over the 3-month intervention period.

OTHER

Nicotine-Free Electronic Cigarette and behavioural change support.

Group B participants will receive nicotine-free cartridges for the period of the intervention. All participants will receive up to 6 behavioural change support sessions over the 3-month intervention period.

OTHER

Nicotine Replacement Therapy and behavioural change support.

Group C participants will be referred to smoking cessation services where they will be expected to receive Nicotine Replacement Therapy and up to 6 behavioural change support sessions over the 3-month intervention period, as per current guidelines.

Trial Locations (1)

S10 2BP

Sheffield Hallam University, Sheffield

All Listed Sponsors
collaborator

King's College London

OTHER

collaborator

Heart Research U.K.

UNKNOWN

collaborator

Help2Change

UNKNOWN

lead

Sheffield Hallam University

OTHER

NCT03061253 - E-cigarettes and Cardiovascular Function | Biotech Hunter | Biotech Hunter